249 related articles for article (PubMed ID: 18555052)
21. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission.
Yen CF; Cheng CP; Huang CF; Yen JY; Ko CH; Chen CS
Bipolar Disord; 2008 Jul; 10(5):617-24. PubMed ID: 18657246
[TBL] [Abstract][Full Text] [Related]
22. Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study.
Bonnín CM; Martínez-Arán A; Torrent C; Pacchiarotti I; Rosa AR; Franco C; Murru A; Sanchez-Moreno J; Vieta E
J Affect Disord; 2010 Feb; 121(1-2):156-60. PubMed ID: 19505727
[TBL] [Abstract][Full Text] [Related]
23. Cognitive functions in bipolar affective disorder and schizophrenia: comparison.
Pradhan BK; Chakrabarti S; Nehra R; Mankotia A
Psychiatry Clin Neurosci; 2008 Oct; 62(5):515-25. PubMed ID: 18950370
[TBL] [Abstract][Full Text] [Related]
24. Changes of insight in manic episodes and influencing factors.
Yen CF; Chen CS; Yeh ML; Yang SJ; Ke JH; Yen JY
Compr Psychiatry; 2003; 44(5):404-8. PubMed ID: 14505301
[TBL] [Abstract][Full Text] [Related]
25. Reliability and validity of the Korean version of UKU-SERS-Pat in patients with bipolar disorder.
Kim JH; Choi SW; Joe SH; Ha TH; Yoo HJ; Choi JE; Cha B; Ha K
Nord J Psychiatry; 2008; 62(6):496-502. PubMed ID: 18841509
[TBL] [Abstract][Full Text] [Related]
26. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients.
Mur M; Portella MJ; Martínez-Arán A; Pifarré J; Vieta E
J Clin Psychiatry; 2008 May; 69(5):712-9. PubMed ID: 18435565
[TBL] [Abstract][Full Text] [Related]
27. Neurocognition in first-degree healthy relatives (siblings) of bipolar affective disorder patients.
Trivedi JK; Goel D; Dhyani M; Sharma S; Singh AP; Sinha PK; Tandon R
Psychiatry Clin Neurosci; 2008 Apr; 62(2):190-6. PubMed ID: 18412842
[TBL] [Abstract][Full Text] [Related]
28. The predictive effect of insight on adverse clinical outcomes in bipolar I disorder: a two-year prospective study.
Yen CF; Chen CS; Yen JY; Ko CH
J Affect Disord; 2008 May; 108(1-2):121-7. PubMed ID: 17997489
[TBL] [Abstract][Full Text] [Related]
29. Measurement of insight in patients with bipolar disorder: are self-rated scales developed for patients with schizophrenia applicable?
Jónsdóttir H; Engh JA; Friis S; Birkenaes A; Ringen PA; Vaskinn A; Sundet K; Opjordsmoen S; Andreassen OA
J Nerv Ment Dis; 2008 Apr; 196(4):333-5. PubMed ID: 18414129
[TBL] [Abstract][Full Text] [Related]
30. Neurocognition as a stable endophenotype in bipolar disorder and schizophrenia.
Burdick KE; Goldberg JF; Harrow M; Faull RN; Malhotra AK
J Nerv Ment Dis; 2006 Apr; 194(4):255-60. PubMed ID: 16614546
[TBL] [Abstract][Full Text] [Related]
31. A relationship between neurocognitive impairment and functional impairment in bipolar disorder: a pilot study.
Altshuler LL; Bearden CE; Green MF; van Gorp W; Mintz J
Psychiatry Res; 2008 Jan; 157(1-3):289-93. PubMed ID: 17868903
[TBL] [Abstract][Full Text] [Related]
32. Neuropsychological and symptom predictors of aggression on the psychiatric inpatient service.
Serper M; Beech DR; Harvey PD; Dill C
J Clin Exp Neuropsychol; 2008 Aug; 30(6):700-9. PubMed ID: 18608673
[TBL] [Abstract][Full Text] [Related]
33. Residual symptoms in bipolar disorder: the effect of the last episode after remission.
Kaya E; Aydemir O; Selcuki D
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1387-92. PubMed ID: 17628288
[TBL] [Abstract][Full Text] [Related]
34. Neuropsychological and electrophysiological indices of neurocognitive dysfunction in bipolar II disorder.
Andersson S; Barder HE; Hellvin T; Løvdahl H; Malt UF
Bipolar Disord; 2008 Dec; 10(8):888-99. PubMed ID: 19594504
[TBL] [Abstract][Full Text] [Related]
35. Suicide behavior and neuropsychological assessment of type I bipolar patients.
Malloy-Diniz LF; Neves FS; Abrantes SS; Fuentes D; Corrêa H
J Affect Disord; 2009 Jan; 112(1-3):231-6. PubMed ID: 18485487
[TBL] [Abstract][Full Text] [Related]
36. The Maudsley Bipolar Disorder Project: the effect of medication, family history, and duration of illness on IQ and memory in bipolar I disorder.
Donaldson S; Goldstein LH; Landau S; Raymont V; Frangou S
J Clin Psychiatry; 2003 Jan; 64(1):86-93. PubMed ID: 12590629
[TBL] [Abstract][Full Text] [Related]
37. Suicidality and its association with insight and neurocognition in taiwanese patients with bipolar I disorder in remission.
Yen CF; Cheng CP; Ko CH; Yen JY; Huang CF; Chen CS
J Nerv Ment Dis; 2008 Jun; 196(6):462-7. PubMed ID: 18552623
[TBL] [Abstract][Full Text] [Related]
38. Sustained attention deficits in manic and euthymic patients with bipolar disorder.
Bora E; Vahip S; Akdeniz F
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1097-102. PubMed ID: 16740350
[TBL] [Abstract][Full Text] [Related]
39. Insight in bipolar disorder: associations with cognitive and emotional processing and illness characteristics.
van der Werf-Eldering MJ; van der Meer L; Burger H; Holthausen EA; Nolen WA; Aleman A
Bipolar Disord; 2011 Jun; 13(4):343-54. PubMed ID: 21843274
[TBL] [Abstract][Full Text] [Related]
40. Assessment of medication adherence in a cohort of patients with bipolar disorder.
González-Pinto A; Reed C; Novick D; Bertsch J; Haro JM
Pharmacopsychiatry; 2010 Nov; 43(7):263-70. PubMed ID: 20842617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
